GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Northland Biotech Co Ltd (BJSE:430047) » Definitions » EV-to-EBITDA

Beijing Northland Biotech Co (BJSE:430047) EV-to-EBITDA : -111.66 (As of May. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Beijing Northland Biotech Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Beijing Northland Biotech Co's enterprise value is ¥4,216.90 Mil. Beijing Northland Biotech Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-37.77 Mil. Therefore, Beijing Northland Biotech Co's EV-to-EBITDA for today is -111.66.

The historical rank and industry rank for Beijing Northland Biotech Co's EV-to-EBITDA or its related term are showing as below:

BJSE:430047' s EV-to-EBITDA Range Over the Past 10 Years
Min: -473.84   Med: -82.42   Max: -32.22
Current: -114.79

During the past 13 years, the highest EV-to-EBITDA of Beijing Northland Biotech Co was -32.22. The lowest was -473.84. And the median was -82.42.

BJSE:430047's EV-to-EBITDA is ranked worse than
100% of 448 companies
in the Biotechnology industry
Industry Median: 10.08 vs BJSE:430047: -114.79

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Beijing Northland Biotech Co's stock price is ¥15.57. Beijing Northland Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.180. Therefore, Beijing Northland Biotech Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Beijing Northland Biotech Co EV-to-EBITDA Historical Data

The historical data trend for Beijing Northland Biotech Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Northland Biotech Co EV-to-EBITDA Chart

Beijing Northland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -236.55 -211.39 -148.04 -63.95 -126.44

Beijing Northland Biotech Co Quarterly Data
Mar19 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.43 -50.66 -57.60 -126.44 -116.48

Competitive Comparison of Beijing Northland Biotech Co's EV-to-EBITDA

For the Biotechnology subindustry, Beijing Northland Biotech Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Northland Biotech Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Northland Biotech Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Beijing Northland Biotech Co's EV-to-EBITDA falls into.



Beijing Northland Biotech Co EV-to-EBITDA Calculation

Beijing Northland Biotech Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4216.896/-37.766
=-111.66

Beijing Northland Biotech Co's current Enterprise Value is ¥4,216.90 Mil.
Beijing Northland Biotech Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-37.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Northland Biotech Co  (BJSE:430047) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Beijing Northland Biotech Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=15.57/-0.180
=At Loss

Beijing Northland Biotech Co's share price for today is ¥15.57.
Beijing Northland Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.180.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Beijing Northland Biotech Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Beijing Northland Biotech Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Northland Biotech Co (BJSE:430047) Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Shangdi Kaikai Road, A406, Zhongguancun Biomedical Park, Haidian District, Beijing, CHN, 100085
Beijing Northland Biotech Co Ltd is a biopharmaceutical company specializing in the research and development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs.

Beijing Northland Biotech Co (BJSE:430047) Headlines

No Headlines